Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 4, 2021
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
[ Thu, Mar 04th 2021
] - WOPRAI
Wed, March 3, 2021
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
[ Wed, Mar 03rd 2021
] - WOPRAI
Salveen Richter Downgraded (ADPT) to Hold and Decreased Target to $63 on, Mar 3rd, 2021
Salveen Richter of Goldman Sachs, Downgraded "Adaptive Biotechnologies Corporation" (ADPT) to Hold and Decreased Target from $74 to $63 on, Mar 3rd, 2021.
Salveen has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tejas Savant of "Morgan Stanley" Maintained at Hold with Increased Target to $60 on, Friday, February 26th, 2021
